Biologics Licence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Market closes in the red after testing news highs in early trading

The Australian share market ignored the softer lead from US markets overnight to test new highs in early trading, before late afternoon selling pushed the index into the red.

South koreaSouth koreanHanwha oceanLanger heinrichDow jonesNewmont corporationPaladin energyNetwealth groupMeridian energyRamsay health careCommunications servicesCommunication servicesEaster mondayBiologics licenceEvolution miningPremier investments

OCGN Stock: Seems Unattractive With Regulatory Uncertainties

OCGN Stock: Seems Unattractive With Regulatory Uncertainties
investorplace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorplace.com Daily Mail and Mail on Sunday newspapers.

United statesCansino biologicsDrug administrationSerum institute of indiaOpportunity for ocugenBharat biotechBiologics licenceSerum institute

No EUA to Covaxin in USA: FDA recommends Biologics Licence Application route for approval

URL copied No EUA to Covaxin in USA: FDA recommends Biologics Licence Application route for approval In setback that could potentially delay the launch of Bharat Biotech s COVID-19 vaccine Covaxin in USA, the Food and Drug Administration there has recommended Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixing hopes of Emergency Use Authorisation (EUA). Ocugen in a statement on Thursday announced that as recommended by the FDA, it will pursue submission of a biologics licence application (BLA) for Covaxin. BLA is a full approval mechanism by the FDA for drugs and vaccines.Â The development may delay the Covaxin launch in the US, Ocugen said.

United statesShankar musunuriDrug administrationHealth canadaOcugen incBiologics licenceImage sourceBiologics licence applicationBharat biotechEmergency use authorisationEmergency use authorizationChief executive officerInterim order respectingBharat biotech covid 19 vaccineOcugen incBiologics licence application